Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 6, Pages 1389-1398
Publisher
Wiley
Online
2013-08-09
DOI
10.1002/ijc.28425
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Four-Year Follow-up of the Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine When Administered to Adolescent Girls Aged 10–14 Years
- (2012) Tino F. Schwarz et al. JOURNAL OF ADOLESCENT HEALTH
- Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
- (2012) Cathy Ndiaye et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Worldwide burden of cervical cancer in 2008
- (2011) M. Arbyn et al. ANNALS OF ONCOLOGY
- Cervical cancer treatment in Africa
- (2011) Lynette Denny CURRENT OPINION IN ONCOLOGY
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa
- (2011) Hugo De Vuyst et al. INTERNATIONAL JOURNAL OF CANCER
- Preventable Exposures Associated With Human Cancers
- (2011) V. J. Cogliano et al. JNCI-Journal of the National Cancer Institute
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: A case-control study
- (2010) Georgette Adjorlolo-Johnson et al. BMC INFECTIOUS DISEASES
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication
- (2010) Ni Li et al. INTERNATIONAL JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women
- (2010) N. De Carvalho et al. VACCINE
- Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria
- (2010) Clement Okolo et al. Infectious Agents and Cancer
- HPV infection in women with and without cervical cancer in Conakry, Guinea
- (2009) N Keita et al. BRITISH JOURNAL OF CANCER
- Human Papillomavirus Infection and Cervical Cytology in HIV‐Infected and HIV‐Uninfected Rwandan Women
- (2009) Diljeet K. Singh et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- New Quadrivalent HPV Vaccine Developments
- (2009) John M. Tovar et al. POSTGRADUATE MEDICINE
- Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review
- (2009) Karly S. Louie et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Human Papillomavirus type distribution in invasive cervical cancer in Uganda
- (2008) Michael Odida et al. BMC INFECTIOUS DISEASES
- Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix???]
- (2008) Susan J Keam et al. DRUGS
- History of the FIGO cancer staging system
- (2008) Franco Odicino et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Part I: Cancer in Indigenous Africans—burden, distribution, and trends
- (2008) D Max Parkin et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now